Laura Loman - Concepedia

Author

Laura Loman

University Medical Center Groningen ORCID

Also Known As

L Loman, L. Loman, Laura Loman

Publications

620

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen University Medical Center Utrecht Radboud University Nijmegen Radboud University Medical Center

About

Laura Loman is an author at University Medical Center Groningen specializing in medicine, dermatology, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	68
2	Allergy	2	2	68
3	Allergy Medicine	2	2	68
4	Health Sciences	1	1	15
5	Public Health	1	1	15

Laura Loman

Publications

550

Citations

H-Index

Page 1

	Year	Citations
Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis Lotte S. Spekhorst, Daphne S. Bakker, Julia Drylewicz, Allergy	2022	54
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis Lotte S. Spekhorst, Marlies de Graaf, Nicolaas P. A. Zuithoff, JAMA Dermatology	2022	42
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry Lotte S. Spekhorst, Celeste M. Boesjes, Laura Loman, British Journal of Dermatology	2023	38
Hyperkeratotic hand eczema: Eczema or not? Klaziena Politiek, Laura Loman, Hendri H. Pas, Contact Dermatitis	2020	35
Three cases of non‐atopic hyperkeratotic hand eczema treated with dupilumab Laura Loman, Gilles F.H. Diercks, Marie L. A. Schuttelaar Contact Dermatitis AllergyOphthalmologyAutoimmune DiseaseAllergy MedicineMedicine	2020	34
Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, Acta Dermato Venereologica RheumatologyAllergyBioday RegistryAtopic DermatitisAllergy Medicine	2024	34
Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study Angelique N. Voorberg, Laura Loman, Marie L. A. Schuttelaar Acta Dermato Venereologica	2021	31
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the <scp>BioDay</scp> registry Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, Pediatric Allergy and Immunology	2022	27
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry Junfen Zhang, Celeste M. Boesjes, Laura Loman, Journal of the American Academy of Dermatology	2024	26
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis Celeste M. Boesjes, Esmé Kamphuis, Marlies de Graaf, JAMA Dermatology	2024	24

Page 1